A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris

Clinical trial NCT01116895 · COMPLETED

Trial details

NCT number: NCT01116895
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2010-05-01
Primary completion: 2011-03-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.